Literature DB >> 28630309

QnAs with Tony Hunter and James Allison.

Prashant Nair.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28630309      PMCID： PMC5495289          DOI： 10.1073/pnas.1707946114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities.

Authors:  Sumit K Subudhi; Ana Aparicio; Jianjun Gao; Amado J Zurita; John C Araujo; Christopher J Logothetis; Salahaldin A Tahir; Brinda R Korivi; Rebecca S Slack; Luis Vence; Ryan O Emerson; Erik Yusko; Marissa Vignali; Harlan S Robins; Jingjing Sun; James P Allison; Padmanee Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

2.  Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.

Authors:  Andreas Hochhaus; Richard A Larson; François Guilhot; Jerald P Radich; Susan Branford; Timothy P Hughes; Michele Baccarani; Michael W Deininger; Francisco Cervantes; Satoko Fujihara; Christine-Elke Ortmann; Hans D Menssen; Hagop Kantarjian; Stephen G O'Brien; Brian J Druker
Journal:  N Engl J Med       Date:  2017-03-09       Impact factor: 91.245

3.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

4.  An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates.

Authors:  W Eckhart; M A Hutchinson; T Hunter
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

5.  Enhancement of antitumor immunity by CTLA-4 blockade.

Authors:  D R Leach; M F Krummel; J P Allison
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.